DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Oxford Immunotec Global Q4 Sales $18.1M Beat $17.06M Estimate

Oxford Immunotec Global (NASDAQ:OXFD) reported quarterly sales of $18.1 million which beat the analyst consensus estimate of $17.06 million by 6.10 percent. This is a 17.78 percent increase over sales of $15.367 million

Benzinga · 03/02/2020 12:04

Oxford Immunotec Global (NASDAQ:OXFD) reported quarterly sales of $18.1 million which beat the analyst consensus estimate of $17.06 million by 6.10 percent. This is a 17.78 percent increase over sales of $15.367 million the same period last year.